The University of Texas at Dallas School of Behavioral and Brain Sciences (BBS) and Office of Research and Innovation have collaborated to create a Clinical Trials Unit, a centralized location and source of support for human trials of therapeutic drugs and devices. The new clinical and translational research unit will facilitate the assessment of new therapies for human disease, focusing initially on behavioral and brain disorders and conditions, and will be available to any UTD researcher. The first clinical trials are anticipated for hearing loss, pain and neurological disease. “I’ve been interested in building the infrastructure necessary for doing applied clinical research here at UT Dallas, and, in my own field of hearing science, efforts have exploded recently to develop drugs for either hearing protection or regeneration,” she said. This new unit will provide the expertise and infrastructure to conduct clinical trials on campus.”To learn more about how UT Dallas is enhancing lives through transformative research, explore New Dimensions: The Campaign for UT Dallas.